IIT-M study reveals how gene interactions act as ‘switches’ behind complex diseases

The team used what is called a multi-omics approach -- they studied genes, proteins, and cell chemicals/metabolites all at once.

Published Sep 02, 2025 | 4:47 PMUpdated Sep 02, 2025 | 4:47 PM

Representational image. Credit: iStock

Synopsis: The scientists compared this “two-switch” mechanism to turning on a hidden backup circuit in an electrical system, suddenly the cell behaves differently because a previously silent pathway comes alive. Such effects, they say, could also occur in higher organisms, including humans.

It is common for people living together, whether in homes, hostels, or shared spaces, to rely on the same prescription if they develop similar symptoms. If one person consults a doctor for a fever, others who fall ill later often use the same medicines, assuming the illness and treatment are the same.

But doctors and scientists increasingly warn that diseases do not behave identically in every patient. The same condition may progress differently depending on a person’s unique genetic makeup.

Now, a joint study by the Indian Institute of Technology-Madras (IIT-Madras) and the Technical University of Denmark has shed new light on this. The researchers found that interactions between multiple genes can act like “switches” that activate hidden biological pathways, providing fresh insights into complex conditions such as cancer, diabetes, and neurodegenerative disorders.

Published in Nature Communications, the research provides a framework for more accurate diagnosis, better prediction of disease progression, and eventually, personalised treatment tailored to each patient’s genetic makeup.

Study details and key findings

The study, Interaction of Genetic Variants Activates Latent Metabolic Pathways in Yeast,” was led by Professor Himanshu Sinha and PhD student Srijith Sasikumar from IIT-M’s Department of Biotechnology, in collaboration with Dr Shannara Taylor Parkins and Dr Suresh Sudarsan from the Technical University of Denmark.

Also Read: New calculator helps doctors choose right medicines for blood pressure

Using yeast as a model organism, the researchers showed that two specific genetic variants, called MKT1(89G) and TAO3(4477C), could work together to switch on a hidden metabolic pathway. Interestingly, when each variant was present on its own, it had little effect. But when both appeared together, they produced an entirely new outcome.

The scientists compared this “two-switch” mechanism to turning on a hidden backup circuit in an electrical system, suddenly the cell behaves differently because a previously silent pathway comes alive. Such effects, they say, could also occur in higher organisms, including humans.

To understand how this change unfolded, the team used what is called a multi-omics approach — they studied genes (transcriptomics), proteins (proteomics), and cell chemicals/metabolites (metabolomics) all at once, and tracked these changes over time.

This helped them see not only what changed inside the cell, but also when the change happened.

In this double-variant situation, the yeast cells activated a pathway that produces arginine (an amino acid important for growth), while at the same time reducing the production of ribosomes (the cell’s protein-making machines).

This trade-off gave the yeast an advantage in reproduction. Importantly, the arginine pathway also became necessary for the cells’ mitochondria, their energy-producing centers, but only when both variants were present, proving that genetic interactions can create new cellular dependencies.

Broader impact of study 

Sinha emphasised that the implications go far beyond yeast, explaining that many human diseases result from the interplay of multiple genes rather than single mutations.

Also Read: Two-thirds of adults remain uninsured despite government schemes

“By combining multi-omics with temporal analysis, we could see not just which pathways were affected, but when and how these changes unfolded,” he said.

“This is especially important for developmental and progressive diseases, where timing of gene interactions can be as critical as the interactions themselves,” he added.

Sasikumar explained that the effect was like “flipping two switches at once,” which suddenly activates a hidden circuit and changes the entire system’s behaviour.

This highlighted how new outcomes can emerge from gene interactions that remain invisible when studying genes in isolation.

The researchers say their findings could be applied in several areas:

  • Better diagnosis and treatment: By identifying biological signals that indicate disease and new drug targets that take combined genetic effects into account, doctors could diagnose diseases more accurately and design medicines tailored to each patient’s genetic makeup.
  • Personalised medicine: Instead of giving the same treatment to all patients with a similar condition, therapies could be adjusted to match a person’s unique genetic background, improving effectiveness and reducing side effects.
  • Synthetic biology and biotechnology: Scientists could use engineered gene interactions to control biological pathways, leading to better production of useful products such as biofuels, pharmaceuticals, or other valuable chemicals.
  • Agriculture and industry: The same principles could help design stress-tolerant crops that survive harsh environments, or industrial microbes that are more efficient in producing food ingredients, medicines, or renewable energy.

(Edited by Amit Vasudev)

Follow us